Industry resources and insights

Sort by year
  • All time
  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020 and older
Articles
05.10.2026
Forecasting PICOs early: What if your final eviden...

Manufacturers should not wait for final HTA scopes to test whether their evidence package can addres...

Read more
Articles
21.09.2026
From Global Price Ambition to Local Access Reality...

Pricing research is often treated as a launch-stage exercise focused on testing a target price. But ...

Read more
Insider Insights
21.09.2026
Is VPAG dead? What comes next for UK medicines pri...

When the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) replaced VPAS in 2...

Read more
Webinar
11.09.2026
Beyond the first JCA: emerging patterns, national ...

The first EU Joint Clinical Assessments (JCAs) are now providing real-world evidence of how the new ...

Read more
Articles
09.09.2026
Choosing payer pricing research? Start with the qu...

Different budget pressures create different payer pricing challenges  Healthcare budget pressur...

Read more
Analysis
19.08.2026
Europe’s First JCAs: Early Signals for Pricing &...

The publication of the first three EU Joint Clinical Assessments (JCAs) provides the first opportuni...

Read more
Load more
Browse by topic
Content type
  • All
  • Analysis
  • Articles
  • Case Studies
  • Checklist
  • Guide
  • Insider Insights
  • News
  • Poster
  • Publications
  • Webinar
  • White Paper
Subscribe
This field is for validation purposes and should be left unchanged.
Consent

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch